|
CO-ADMINISTRATION WITH CIMETIDINE MAY RESULT IN REDUCED CAFFEINE ELIMINATION ; LOWER DOSES OF CAFFEINE MAY BE NEEDED
|
CO-ADMINISTRATION RESULTS IN REDUCED URINE VOLUME IN HEALTHY VOLUNTEERS
|
CO-ADMINISTRATION WITH PHENYTOIN MAY RESULT IN INCREASED CAFFEINE ELIMINATION ; HIGHER DOSES OF CAFFEINE MAY BE NEEDED
|
INTERCONVERSION BETWEEN CAFFEINE AND AMINOPHYLLINE HAS BEEN REPORTED IN PRETERM NEONATES ; THE CONCURRENT USE OF THESE DRUGS IS NOT RECOMMENDED
|
METHYLXANTHINES ARE NON-SPECIFIC ADENOSINE RECEPTOR ANTAGONISTS & MAY INTERFERE WITH THE VASODILATATION ACTIVITY
|
CO-ADMINISTRATION WITH KETOCONAZOLE MAY RESULT IN REDUCED CAFFEINE ELIMINATION ; LOWER DOSES OF CAFFEINE MAY BE NEEDED
|
CO-ADMINISTRATION WITH KETOCONAZOLE MAY RESULT IN REDUCED CAFFEINE ELIMINATION ; LOWER DOSES OF CAFFEINE MAY BE NEEDED
|
CO-ADMINISTRATION WITH KETOCONAZOLE MAY RESULT IN REDUCED CAFFEINE ELIMINATION ; LOWER DOSES OF CAFFEINE MAY BE NEEDED
|
CO-ADMINISTRATION WITH KETOCONAZOLE MAY RESULT IN REDUCED CAFFEINE ELIMINATION ; LOWER DOSES OF CAFFEINE MAY BE NEEDED
|
INTERCONVERSION BETWEEN CAFFEINE AND THEOPHYLLINE HAS BEEN REPORTED IN PRETERM NEONATES ; THE CONCURRENT USE OF THESE DRUGS IS NOT RECOMMENDED
|
INTERCONVERSION BETWEEN CAFFEINE AND THEOPHYLLINE HAS BEEN REPORTED IN PRETERM NEONATES ; THE CONCURRENT USE OF THESE DRUGS IS NOT RECOMMENDED
|
INTERCONVERSION BETWEEN CAFFEINE AND THEOPHYLLINE HAS BEEN REPORTED IN PRETERM NEONATES ; THE CONCURRENT USE OF THESE DRUGS IS NOT RECOMMENDED
|
INTERCONVERSION BETWEEN CAFFEINE AND THEOPHYLLINE HAS BEEN REPORTED IN PRETERM NEONATES ; THE CONCURRENT USE OF THESE DRUGS IS NOT RECOMMENDED
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
ADENOSINE ACTION IS INHIBITED BY THE DRUG
|
CAFFEINE CLEARANCE IS DECREASED BY TERBINAFINE
|